CIAM
MED icon

Caitong International Asset Management’s Medifast MED Stock Holding History

Caitong International Asset Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$326 Buy
32
+3
+10% +$32 ﹤0.01% 1773
2025
Q4 		$310 Buy
+29
New +$347 ﹤0.01% 1548
2025
Q3 		– Sell
-55
Closed -$773 – 2281
2025
Q2 		$773 Sell
55
-227
-80% -$2.98K ﹤0.01% 1629
2025
Q1 		$3.8K Buy
282
+224
+386% +$3.36K ﹤0.01% 1103
2024
Q4 		$1.02K Buy
+58
New +$1.08K ﹤0.01% 1327

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Caitong International Asset Management's MED Position: Q1 2026 in Review

Caitong International Asset Management increased its Medifast (MED) stake by 10% in Q1 2026, buying an estimated $32 and bringing the position to 32 shares worth $326. The position accounts for ﹤0.01% of the portfolio, ranked #1773.

Caitong International Asset Management first reported a position in MED in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.8K in Q1 2025. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • Caitong International Asset Management held 32 shares of Medifast worth $326 as of Q1 2026.
  • Caitong International Asset Management bought 3 Medifast shares in Q1 2026, an estimated $32.
  • Medifast made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1773 holding.
  • Caitong International Asset Management first reported a position in Medifast in Q4 2024 and has held it in 5 quarters since.
  • Caitong International Asset Management's Medifast position peaked at $3.8K in Q1 2025.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.